Fujirebio (Belgium)

Publications in OpenAlex of which a co-author is affiliated to this organization

All publications | By field | By subfield

All publications [Next]
Title DOI
https://doi.org/10.1002/ana.21610 Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects
https://doi.org/10.1073/pnas.94.24.13193 Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy
https://doi.org/10.1038/34910 Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein
https://doi.org/10.1002/hep.20819 Consensus Proposals for a Unified System of Nomenclature of Hepatitis C Virus Genotypes *
https://doi.org/10.1002/hep.1840190538 A proposed system for the nomenclature of hepatitis C viral genotypes
https://doi.org/10.1056/nejm199603283341302 Long-Term Outcome of Hepatitis C Infection after Liver Transplantation
https://doi.org/10.1007/bf02815140 tau protein in cerebrospinal fluid
https://doi.org/10.1038/ng585 Identification of the gene altered in Berardinelli–Seip congenital lipodystrophy on chromosome 11q13
https://doi.org/10.1038/75063 Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C
https://doi.org/10.1016/0304-3940(95)11484-e Monoclonal antibody AT8 recognises tau protein phosphorylated at both serine 202 and threonine 205
https://doi.org/10.1016/0896-6273(94)90264-x Biopsy-derived adult human brain tau is phosphorylated at many of the same sites as Alzheimer's disease paired helical filament tau
https://doi.org/10.1007/s007050050479 Classification, nomenclature, and database development for hepatitis C virus (HCV) and related viruses: proposals for standardization
https://doi.org/10.1111/j.1471-4159.1993.tb09823.x Detection of Proteins in Normal and Alzheimer's Disease Cerebrospinal Fluid with a Sensitive Sandwich Enzyme‐Linked Immunosorbent Assay
https://doi.org/10.1016/s0304-3940(00)01036-3 Quantification of tau phosphorylated at threonine 181 in human cerebrospinal fluid: a sandwich ELISA with a synthetic phosphopeptide for standardization
https://doi.org/10.1093/brain/awac333 Head-to-head comparison of 10 plasma phospho-tau assays in prodromal Alzheimer’s disease
https://doi.org/10.1126/science.1971458 Amyloid β Protein Precursor Gene and Hereditary Cerebral Hemorrhage with Amyloidosis (Dutch)
https://doi.org/10.1074/jbc.m302267200 Cellular Binding of Hepatitis C Virus Envelope Glycoprotein E2 Requires Cell Surface Heparan Sulfate
https://doi.org/10.1001/archneurol.2010.179 Diagnosis-Independent Alzheimer Disease Biomarker Signature in Cognitively Normal Elderly People
https://doi.org/10.1016/s0016-5085(99)70065-x Geographic distribution of vacA allelic types of Helicobacter pylori
https://doi.org/10.1016/s0304-3940(00)01697-9 Transient increase in total tau but not phospho-tau in human cerebrospinal fluid after acute stroke
https://doi.org/10.1093/clinchem/47.10.1776 Tau and Aβ42 in Cerebrospinal Fluid from Healthy Adults 21–93 Years of Age: Establishment of Reference Values
https://doi.org/10.1373/clinchem.2004.039347 Simultaneous Measurement of β-Amyloid(1–42), Total Tau, and Phosphorylated Tau (Thr181) in Cerebrospinal Fluid by the xMAP Technology
https://doi.org/10.1016/j.jalz.2011.05.2243 The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers
https://doi.org/10.1016/s0925-4005(98)00128-2 Nanoscaled interdigitated electrode arrays for biochemical sensors
https://doi.org/10.1053/jhep.2001.27563 Factors associated with hepatitis B virus DNA breakthrough in patients receiving prolonged lamivudine therapy
https://doi.org/10.1016/j.jalz.2013.01.010 CSF biomarker variability in the Alzheimer's Association quality control program
https://doi.org/10.1042/bj3010871 Epitope mapping of monoclonal antibodies to the paired helical filaments of Alzheimer's disease: identification of phosphorylation sites in tau protein
https://doi.org/10.1016/j.jalz.2011.07.004 Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: A consensus paper from the Alzheimer's Biomarkers Standardization Initiative
https://doi.org/10.1017/s135583820101442x Symmetrical dimethylation of arginine residues in spliceosomal Sm protein B/B′ and the Sm-like protein LSm4, and their interaction with the SMN protein
https://doi.org/10.1007/bf00227819 Monoclonal antibodies with selective specificity for Alzheimer Tau are directed against phosphatase-sensitive epitopes
https://doi.org/10.1136/ard.2003.017574 Rheumatoid factor and anticitrullinated protein antibodies in rheumatoid arthritis: diagnostic value, associations with radiological progression rate, and extra-articular manifestations
https://doi.org/10.1016/j.jim.2006.01.022 Anatomy and nomenclature of murine lymph nodes: Descriptive study and nomenclatory standardization in BALB/cAnNCrl mice
https://doi.org/10.1007/s00401-011-0808-0 Qualification of the analytical and clinical performance of CSF biomarker analyses in ADNI
https://doi.org/10.1016/j.jalz.2010.03.008 Update on the biomarker core of the Alzheimer's Disease Neuroimaging Initiative subjects
https://doi.org/10.1053/j.gastro.2007.08.079 Low Resistance to Adefovir Combined With Lamivudine: A 3-Year Study of 145 Lamivudine-Resistant Hepatitis B Patients
https://doi.org/10.3109/13506120009146438 Standardization of measurement of β-amyloid(1-42)in cerebrospinal fluid and plasma
https://doi.org/10.1001/jamaneurol.2015.1285 Longitudinal Cerebrospinal Fluid Biomarker Changes in Preclinical Alzheimer Disease During Middle Age
https://doi.org/10.1586/14789450.5.2.207 Biochemistry of Tau in Alzheimer’s disease and related neurological disorders
https://doi.org/10.1074/jbc.m000300200 The C-terminal RG Dipeptide Repeats of the Spliceosomal Sm Proteins D1 and D3 Contain Symmetrical Dimethylarginines, Which Form a Major B-cell Epitope for Anti-Sm Autoantibodies
https://doi.org/10.1016/j.neurobiolaging.2008.03.027 Evaluation of plasma Aβ40 and Aβ42 as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment
https://doi.org/10.1111/j.1349-7006.2009.01386.x l‐Type amino acid transporter 1 inhibitors inhibit tumor cell growth
https://doi.org/10.1385/mn:24:1-3:087 CSF Total tau, Aβ42 and Phosphorylated tau Protein as Biomarkers for Alzheimer's Disease
https://doi.org/10.1016/s0142-9612(98)00049-0 In vitro and in vivo biocompatibility of dextran dialdehyde cross-linked gelatin hydrogel films
https://doi.org/10.1016/j.neurobiolaging.2007.02.016 Diagnostic performance of a CSF-biomarker panel in autopsy-confirmed dementia
https://doi.org/10.1007/s007020070079 CSF levels of tau, β-amyloid 1-42 and GAP-43 in frontotemporal dementia, other types of dementia and normal aging
https://doi.org/10.1002/hep.20240 HBsAg seroclearance in chronic hepatitis B in the Chinese: Virological, histological, and clinical aspects
https://doi.org/10.1038/sj.mp.4001220 Phospho-tau/total tau ratio in cerebrospinal fluid discriminates Creutzfeldt–Jakob disease from other dementias
https://doi.org/10.1111/j.1440-1827.2008.02319.x L‐type amino‐acid transporter 1 as a novel biomarker for high‐grade malignancy in prostate cancer
https://doi.org/10.1016/s0002-9440(10)64644-5 Prominent Cerebral Amyloid Angiopathy in Transgenic Mice Overexpressing the London Mutant of Human APP in Neurons
https://doi.org/10.1053/jhep.2003.50148 Long–Term Suppression of Hepatitis B E Antigen–Negative Chronic Hepatitis B by 24–Month Interferon Therapy
https://doi.org/10.1128/jcm.02831-14 Hepatitis C Virus Genotype 7, a New Genotype Originating from Central Africa
https://doi.org/10.1046/j.1471-4159.2003.01818.x Truncated beta‐amyloid peptide species in pre‐clinical Alzheimer's disease as new targets for the vaccination approach
https://doi.org/10.1128/jcm.40.9.3341-3345.2002 High Prevalence of Human Papillomavirus (HPV) Infections and High Frequency of Multiple HPV Genotypes in Human Immunodeficiency Virus-Infected Women in Brazil
https://doi.org/10.3233/jad-2000-23-402 Cerebrospinal Fluid Markers for Alzheimer's Disease Evaluated after Acute Ischemic Stroke
https://doi.org/10.1038/s41598-019-49656-2 Machine learning for comprehensive forecasting of Alzheimer’s Disease progression
https://doi.org/10.1016/j.jalz.2018.08.006 Elevated CSF GAP‐43 is Alzheimer's disease specific and associated with tau and amyloid pathology
https://doi.org/10.1016/j.brainres.2010.09.073 Neurogranin in cerebrospinal fluid as a marker of synaptic degeneration in Alzheimer's disease
https://doi.org/10.1016/j.neulet.2008.11.015 Cerebrospinal fluid α-synuclein in neurodegenerative disorders—A marker of synapse loss?
https://doi.org/10.1159/000068478 Cerebrospinal Fluid Beta-Amyloid 42 Is Reduced before the Onset of Sporadic Dementia: A Population-Based Study in 85-Year-Olds
https://doi.org/10.1128/jvi.80.6.2832-2841.2006 Subcellular Localization of Hepatitis C Virus Structural Proteins in a Cell Culture System That Efficiently Replicates the Virus
https://doi.org/10.1002/acn3.50873 Agreement of amyloid PET and CSF biomarkers for Alzheimer's disease on Lumipulse
https://doi.org/10.1001/archneurol.2011.105 Comparison of Analytical Platforms for Cerebrospinal Fluid Measures of β-Amyloid 1-42, Total tau, and P-tau181 for Identifying Alzheimer Disease Amyloid Plaque Pathology
https://doi.org/10.1128/jcm.38.11.3919-3925.2000 Genetic Diversity of Protease and Reverse Transcriptase Sequences in Non-Subtype-B Human Immunodeficiency Virus Type 1 Strains: Evidence of Many Minor Drug Resistance Mutations in Treatment-Naive Patients
https://doi.org/10.1086/432478 Humoral Immune Response in Acute Hepatitis C Virus Infection
https://doi.org/10.1128/jvi.00941-06 Viral and Cellular Determinants of the Hepatitis C Virus Envelope-Heparan SulfateInteraction
https://doi.org/10.1007/s00401-011-0861-8 Factors affecting Aβ plasma levels and their utility as biomarkers in ADNI
https://doi.org/10.1099/00207713-41-2-310 Taxonomy of Moraxellaceae fam. nov., a New Bacterial Family To Accommodate the Genera Moraxella, Acinetobacter, and Psychrobacter and Related Organisms
https://doi.org/10.1515/cclm.2006.258 Analytical performance and clinical utility of the INNOTEST® PHOSPHO-TAU(181P) assay for discrimination between Alzheimer's disease and dementia with Lewy bodies
https://doi.org/10.1186/s13195-019-0550-8 Clinical validation of the Lumipulse G cerebrospinal fluid assays for routine diagnosis of Alzheimer’s disease
https://doi.org/10.1373/clinchem.2004.039735 Effects of Processing and Storage Conditions on Amyloid β (1–42) and Tau Concentrations in Cerebrospinal Fluid: Implications for Use in Clinical Practice
https://doi.org/10.1002/ana.20639 Subgroups of Alzheimer's disease based on cerebrospinal fluid molecular markers
https://doi.org/10.1016/j.cell.2020.12.024 G3BPs tether the TSC complex to lysosomes and suppress mTORC1 signaling
https://doi.org/10.1515/cclm-2021-0651 Validation of the LUMIPULSE automated immunoassay for the measurement of core AD biomarkers in cerebrospinal fluid
https://doi.org/10.1093/brain/awv199 Alzheimer’s disease cerebrospinal fluid biomarker in cognitively normal subjects
https://doi.org/10.1373/clinchem.2006.079327 MESOMARK™: A Potential Test for Malignant Pleural Mesothelioma
https://doi.org/10.1128/jvi.78.15.8322-8332.2004 Hepatitis C Virus Targets DC-SIGN and L-SIGN To Escape Lysosomal Degradation
https://doi.org/10.1016/j.jalz.2012.12.006 Changes in plasma amyloid beta in a longitudinal study of aging and Alzheimer's disease
https://doi.org/10.1016/s0142-9612(97)00164-6 In vitro release characteristics of bioactive molecules from dextran dialdehyde cross-linked gelatin hydrogel films
https://doi.org/10.1002/humu.20107 The molecular basis of classic Ehlers-Danlos syndrome: A comprehensive study of biochemical and molecular findings in 48 unrelated patients
https://doi.org/10.3233/jad-2010-100207 Evaluation of CSF Biomarkers as Predictors of Alzheimer's Disease: A Clinical Follow-Up Study of 4.7 Years
https://doi.org/10.1016/j.jalz.2012.11.003 Global standardization measurement of cerebral spinal fluid for Alzheimer's disease: An update from the Alzheimer's Association Global Biomarkers Consortium
https://doi.org/10.3233/jad-2007-12307 Intra-Individual Stability of CSF Biomarkers for Alzheimer's Disease over Two Years
https://doi.org/10.1128/jcm.02390-07 Evaluation of Versant Hepatitis C Virus Genotype Assay (LiPA) 2.0
https://doi.org/10.1016/j.jalz.2018.05.008 The impact of preanalytical variables on measuring cerebrospinal fluid biomarkers for Alzheimer's disease diagnosis: A review
https://doi.org/10.2217/17520363.2.4.363 Tau as a Biomarker of Neurodegenerative Diseases
https://doi.org/10.1046/j.1462-2920.2002.00321.x Pseudomonas aeruginosa displays an epidemic population structure
https://doi.org/10.1093/mutage/11.5.485 Cytogenetic studies of PCB77 on brown trout (Salmo trutta fario) using the micronucleus test and the alkaline comet assay
https://doi.org/10.1002/alz.12316 The Alzheimer's Association international guidelines for handling of cerebrospinal fluid for routine clinical measurements of amyloid β and tau
https://doi.org/10.1002/hep.21377 A comprehensive system for consistent numbering of HCV sequences, proteins and epitopes
https://doi.org/10.1007/s00701-007-1489-2 Serum levels of S100B, S100A1B and S100BB are all related to outcome after severe traumatic brain injury
https://doi.org/10.1016/j.expneurol.2009.07.024 Amyloid β peptides in plasma in early diagnosis of Alzheimer's disease: A multicenter study with multiplexing
https://doi.org/10.1016/j.neurobiolaging.2006.12.010 Multiplexed quantification of dementia biomarkers in the CSF of patients with early dementias and MCI: A multicenter study
https://doi.org/10.1093/hmg/8.8.1529 Aberrant Splicing in the Presenilin-1 Intron 4 Mutation Causes Presenile Alzheimer's Disease by Increased A 42 Secretion
https://doi.org/10.1002/ana.25809 SCN3A‐Related Neurodevelopmental Disorder: A Spectrum of Epilepsy and Brain Malformation
https://doi.org/10.1002/alz.12000 Concordance of Lumipulse cerebrospinal fluid t‐tau/Aβ42 ratio with amyloid PET status
https://doi.org/10.1016/j.jalz.2013.10.004 Increased CSF α‐synuclein levels in Alzheimer's disease: Correlation with tau levels
https://doi.org/10.1373/clinchem.2014.236679 Importance and Impact of Preanalytical Variables on Alzheimer Disease Biomarker Concentrations in Cerebrospinal Fluid
https://doi.org/10.1002/alz.12145 First amyloid β1‐42 certified reference material for re‐calibrating commercial immunoassays
https://doi.org/10.1002/dad2.12182 Comparing CSF amyloid‐beta biomarker ratios for two automated immunoassays, Elecsys and Lumipulse, with amyloid PET status
https://doi.org/10.1515/cclm-2015-0733 Assessing the commutability of reference material formats for the harmonization of amyloid-β measurements